Beone Medicines Ltd. Class A · SSE:688235
Oyler John sold 3,693 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 18, 2026
On Jun 16, 2026, Oyler John (Director, Chief Executive Officer) sold 3,693 Beone Medicines Ltd. Class A shares at an average US$265.55 for US$981K, leaving 0 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 3,693 shares
- Price
- US$265.55 average (US$264.87 to US$266.69)
- Value
- US$981K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | American Depositary Shares | Sale | 1,650 | US$264.87 | 2,043 | Direct |
| Jun 16, 2026 | American Depositary Shares | Sale | 1,710 | US$265.99 | 333 | Direct |
| Jun 16, 2026 | American Depositary Shares | Sale | 333 | US$266.69 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Oyler John
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Oyler John · Aug 12, 2026
- Form 4 · Oyler John · Jul 22, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026